Zubair Ahmed, PhD
Professor of Otorhinolaryngology–Head & Neck Surgery and Ophthalmology 
University of Maryland School of Medicine

Delivery of the CIB2 Gene to the Retina as a Therapy for Dry AMD
The Ahmed lab has shown that lowered levels of CIB2 protein can contribute to Dry Age-related Macular Degeneration (AMD). Restoring a functional CIB gene to retinal cells by gene therapy is a promising treatment for this disease.

For more information about this technology, please contact the UM Ventures, Baltimore team.

Yuxing Li, PhD
Professor of Microbiology and Immunology
University of Maryland School of Medicine

Novel Clostridium difficile Binary Toxin Neutralizing Antibody as Therapeutic Agent
C. difficile bacteria produce toxins that damage the intestinal mucosa, causing severe illness and even death. This project explores the use of new toxin-neutralizing antibodies that could blunt the impact of this infection. 

For more information about this technology, please contact the UM Ventures, Baltimore team.

Sarah Murthi, MD
Professor of Surgery
University of Maryland School of Medicine

RecoVRme: Virtual Reality (VR) to Decrease Pain, Reduce Opioid Use, and Promote Recovery
Alternatives to powerful, addictive drugs are needed to manage pain.  In early trials, VR diminished its perceived intensity.  Machine learning and artificial intelligence will be used to design an improved, immersive VR environment.

For more information about this technology, please contact the UM Ventures, Baltimore team.

Joseph Rabin, MD
Associate Professor of Surgery
University of Maryland School of Medicine

TEABO – A minimally invasive strategy to control hemorrhage
Uncontrolled bleeding in the torso can quickly lead to shock, then death. The Trans-Esophageal Aortic Blood flow Occluder is a portable device being developed for use by medics in the field, when caring for victims of severe trauma.

For more information about this technology, please contact the UM Ventures, Baltimore team.

Rajabrata (Raj) Sarkar, MD, PhD
Barbara Baur Dunlap Professor of Surgery
University of Maryland School of Medicine

Developing the Automated Vascular Access Device (AVAD)
Central artery and vein catheterization are common in-hospital procedures but require highly trained physicians. Even so, complications are frequent. The AVAD will be portable, usable by many practitioners, and have a low error rate.

For more information about this technology, please contact the UM Ventures, Baltimore team.

Kathie Seley-Radtke, PhD
Professor, Department of Chemistry and Biochemistry
University of Maryland, Baltimore County

UM-BILD Translational Project
Development of Broad-Spectrum Antiviral Inhibitors

Yan Shu, MD, PhD
Professor of Pharmaceutical Sciences
University of Maryland School of Pharmacy

YA6060, A Novel Small Molecule to Treat Human Cancer and Metabolic Diseases
YA6060 is a new molecule that impacts two key signaling pathways (Wnt & AMPK) exploited by many cancer cells.  This project will evaluate its effects against a challenging preclinical model of colon cancer, the 2nd most lethal cancer in the U.S.

For more information about this technology, please contact the UM Ventures, Baltimore team.

Ian Stockwell, PhD
Associate Professor, Department of Information Systems
University of Maryland, Baltimore County

UM-BILD Translational Project
A Model Agnostic Prediction Infrastructure

Paul Buehler, PharmD, PhD
Professor of Pathology
University of Maryland School of Medicine

A Fiberoptic catheter to measure O2 saturation
Reliable measures of arterial blood are essential for ill patients. The Buehler team is developing a catheter combining blood pressure sensors and pulse oximetry, in a way that delivers high accuracy for all patients, even those with pigmented skin.

For more information, please contact the UM Ventures, Baltimore team.

Amal Isaiah, MBBS, DPhil, MBA
Professor of Otorhinolaryngology-Head & Neck Surgery
University of Maryland School of Medicine

A device to monitor intraocular pressure (IOP)
About 10% of blindness in the U.S is caused by glaucoma, the condition where IOP is too high. To treat it, IOP must be monitored. The FireFly will combine a camera with AI to offer a gentle, no-touch measure of IOP that is suited for home use.

For more information, please contact the UM Ventures, Baltimore team.

Najma Jamaludeen, MS
Lecturer, Family & Consumer Sciences
Morgan State University

UM-BILD Translational Project
Novel apparel for diabetic patients